FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3185953121> ?p ?o ?g. }

• W3185953121 endingPage "e0255274" @default.
• W3185953121 startingPage "e0255274" @default.
• W3185953121 abstract "To clarify whether antiparkinsonian drugs contribute to nocturnal sleep disturbances in patients with Parkinson's disease (PD).Although the major antiparkinsonian drugs L-dopa and dopamine agonists (DAs) have been found to affect sleep, little is known about the effects of specific drugs on sleep in PD patients.The study participants consisted of 112 PD patients (median age 72.5 years [inter-quartile range: IQR 65-79]; mean disease duration 8.44 years [standard deviation: 7.33]; median Hoehn and Yahr stage 3 [IQR 2-3.75]) taking one of three types of non-ergot extended-release DAs (rotigotine 32; pramipexole 44; ropinirole 36) with or without L-dopa (median daily total dosage of antiparkinsonian drugs 525.5 mg [IQR 376.25-658] levodopa equivalent dose [LED]). Participants were assessed using the PD Sleep Scale-2 (PDSS-2).For the whole PD patient cohort, the PDSS-2 sleep disturbance domain score and the scores for item 1 assessing sleep quality and item 8 assessing nocturia were positively correlated with daily total dosage of antiparkinsonian drugs and dosage of L-dopa, but not with the dosage of DAs. Sub-analysis according to DA treatment revealed that DA dosage was not correlated with item 1 or 8 score in any of the subgroups. The LED ratio of rotigotine to the total dosage of antiparkinsonian drugs was inversely correlated with the item 1 score.These data suggest that antiparkinsonian drugs, in particular L-dopa, adversely affect nocturnal sleep in PD patients, especially in terms of sleep quality and nocturia. Thus, adjusting both the total dosage of antiparkinsonian drugs and the dose-ratio of L-dopa might be key actions for alleviating poor sleep quality in patients with PD. Among DAs, we found a clear positive correlation between the dose-ratio of rotigotine and sleep quality. Thus, partial L-dopa replacement with rotigotine could improve sleep quality in patients with PD." @default.
• W3185953121 created "2021-08-02" @default.
• W3185953121 creator A5000461918 @default.
• W3185953121 creator A5000597032 @default.
• W3185953121 creator A5009188534 @default.
• W3185953121 creator A5009363010 @default.
• W3185953121 creator A5010992819 @default.
• W3185953121 creator A5028928062 @default.
• W3185953121 creator A5034256687 @default.
• W3185953121 creator A5039543515 @default.
• W3185953121 creator A5048320698 @default.
• W3185953121 creator A5048648893 @default.
• W3185953121 creator A5050830875 @default.
• W3185953121 creator A5051331240 @default.
• W3185953121 creator A5059392741 @default.
• W3185953121 creator A5064590336 @default.
• W3185953121 creator A5068574176 @default.
• W3185953121 creator A5076770744 @default.
• W3185953121 creator A5082782029 @default.
• W3185953121 creator A5089172358 @default.
• W3185953121 creator A5090752457 @default.
• W3185953121 date "2021-07-28" @default.
• W3185953121 modified "2023-10-14" @default.
• W3185953121 title "Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson’s disease" @default.
• W3185953121 cites W1734979942 @default.
• W3185953121 cites W1895780774 @default.
• W3185953121 cites W1976317445 @default.
• W3185953121 cites W1977726180 @default.
• W3185953121 cites W1984432498 @default.
• W3185953121 cites W1990967797 @default.
• W3185953121 cites W2012644536 @default.
• W3185953121 cites W2047656489 @default.
• W3185953121 cites W2060020865 @default.
• W3185953121 cites W2064996887 @default.
• W3185953121 cites W2068880526 @default.
• W3185953121 cites W2089085990 @default.
• W3185953121 cites W2112455323 @default.
• W3185953121 cites W2114135485 @default.
• W3185953121 cites W2130736332 @default.
• W3185953121 cites W2155030692 @default.
• W3185953121 cites W2274773826 @default.
• W3185953121 cites W2607846415 @default.
• W3185953121 cites W2753051298 @default.
• W3185953121 cites W2936280615 @default.
• W3185953121 doi "https://doi.org/10.1371/journal.pone.0255274" @default.
• W3185953121 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8318227" @default.
• W3185953121 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34320022" @default.
• W3185953121 hasPublicationYear "2021" @default.
• W3185953121 type Work @default.
• W3185953121 sameAs 3185953121 @default.
• W3185953121 citedByCount "3" @default.
• W3185953121 countsByYear W31859531212022 @default.
• W3185953121 countsByYear W31859531212023 @default.
• W3185953121 crossrefType "journal-article" @default.
• W3185953121 hasAuthorship W3185953121A5000461918 @default.
• W3185953121 hasAuthorship W3185953121A5000597032 @default.
• W3185953121 hasAuthorship W3185953121A5009188534 @default.
• W3185953121 hasAuthorship W3185953121A5009363010 @default.
• W3185953121 hasAuthorship W3185953121A5010992819 @default.
• W3185953121 hasAuthorship W3185953121A5028928062 @default.
• W3185953121 hasAuthorship W3185953121A5034256687 @default.
• W3185953121 hasAuthorship W3185953121A5039543515 @default.
• W3185953121 hasAuthorship W3185953121A5048320698 @default.
• W3185953121 hasAuthorship W3185953121A5048648893 @default.
• W3185953121 hasAuthorship W3185953121A5050830875 @default.
• W3185953121 hasAuthorship W3185953121A5051331240 @default.
• W3185953121 hasAuthorship W3185953121A5059392741 @default.
• W3185953121 hasAuthorship W3185953121A5064590336 @default.
• W3185953121 hasAuthorship W3185953121A5068574176 @default.
• W3185953121 hasAuthorship W3185953121A5076770744 @default.
• W3185953121 hasAuthorship W3185953121A5082782029 @default.
• W3185953121 hasAuthorship W3185953121A5089172358 @default.
• W3185953121 hasAuthorship W3185953121A5090752457 @default.
• W3185953121 hasBestOaLocation W31859531211 @default.
• W3185953121 hasConcept C126322002 @default.
• W3185953121 hasConcept C137183658 @default.
• W3185953121 hasConcept C2777333188 @default.
• W3185953121 hasConcept C2777453868 @default.
• W3185953121 hasConcept C2778258207 @default.
• W3185953121 hasConcept C2778717949 @default.
• W3185953121 hasConcept C2779134260 @default.
• W3185953121 hasConcept C2779424955 @default.
• W3185953121 hasConcept C2779734285 @default.
• W3185953121 hasConcept C2779989193 @default.
• W3185953121 hasConcept C2780304432 @default.
• W3185953121 hasConcept C513476851 @default.
• W3185953121 hasConcept C71924100 @default.
• W3185953121 hasConcept C77411442 @default.
• W3185953121 hasConcept C98274493 @default.
• W3185953121 hasConceptScore W3185953121C126322002 @default.
• W3185953121 hasConceptScore W3185953121C137183658 @default.
• W3185953121 hasConceptScore W3185953121C2777333188 @default.
• W3185953121 hasConceptScore W3185953121C2777453868 @default.
• W3185953121 hasConceptScore W3185953121C2778258207 @default.
• W3185953121 hasConceptScore W3185953121C2778717949 @default.
• W3185953121 hasConceptScore W3185953121C2779134260 @default.
• W3185953121 hasConceptScore W3185953121C2779424955 @default.
• W3185953121 hasConceptScore W3185953121C2779734285 @default.

• next